Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Wednesday, March 27, 2024 | Back issues
Courthouse News Service Courthouse News Service

Medtronic Class Action

MINNEAPOLIS - Top officers at Medtronic made false and misleading statements about its Infuse Bone Graft and the share price dropped by 24 percent after the truth came out, shareholders claim in a federal class action.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...